Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

ImmuPharma PLC (IMM)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
2.08 +0.06    +2.97%
08/05 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 1,046,404
  • Bid/Ask: 1.80 / 2.20
  • Day's Range: 1.91 - 2.19
Type:  Equity
Market:  United Kingdom
ISIN:  GB0033711010 
SEDOL:  3371101
ImmuPharma 2.08 +0.06 +2.97%

ImmuPharma Company Profile

 
Read the ImmuPharma PLC company profile to learn more about the business and the management team. View ImmuPharma PLC facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

13

Equity Type

ORD

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company’s lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The company has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. ImmuPharma plc was founded in 1999 and is headquartered in London, the United Kingdom.

Contact Information

Address 1 Bartholomew Close
London, EC1A 7BL
United Kingdom
Phone 44 20 7206 2650
Fax -
Web www.immupharma.co.uk

Top Executives

Name Age Since Title
Timothy Paul McCarthy 65 2015 Chairman & CEO
Lisa Baderoon - 2012 Head of Investor Relations & Non Executive Director
Timothy Gary Franklin - 2020 COO & Director
Daniel J. Wallace - 2013 Member of Scientific Advisory Board
Lee S. Simon 72 2013 Member of Scientific Advisory Board
Vibeke S. Strand - 2013 Member of Scientific Advisory Board
David A. Isenberg - 2013 Member of Scientific Advisory Board
Cees GM Kallenberg - 2013 Member of Scientific Advisory Board
Sébastien R. Goudreau - 2022 CEO of ImmuPharma Biotec & Director
Laurence Reilly - 2023 Senior independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

IMM Price Commentary

Write your thoughts about ImmuPharma PLC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ken Laing
Ken Laing Oct 26, 2023 5:34
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Back in with 500k shares
Reply
0 0
Report
Gary Smith
Gary Smith Oct 26, 2023 5:34
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Gonna lose your investment here. Bullshitter Tim M sent a conpany under before losing investors their savings. A repeat happening here. Lanstead death spiral borrowing killing the conpany
Reply
0 0
Report
Gary Smith
Gary Smith Oct 23, 2023 13:54
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The writing is on the wall for IMM and it’s inept bullshitting McCarthy. Failed before losing shareholders theit investments and it’s happening again
Reply
0 0
Report
Gary Smith
Gary Smith Sep 15, 2023 10:21
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
CEO failed before losing shareholders their life savings and looks like history repeating itself. 10 years of false promises and zero delivery
Reply
0 0
Report
Ken Laing
Ken Laing Aug 22, 2023 9:40
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Glad I took my 10% gain and ran to the exit early this year
Reply
0 0
Report
Gary Smith
Gary Smith Jul 25, 2023 8:56
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
£3m Placing at 1.5p on the way
Reply
0 0
Report
Mo Nawaz
Mo Nawaz Jun 19, 2023 8:41
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
should start to move north over the next few months now follow FDA approval for phase 2/3 clinical trial.
Reply
0 0
Report
Mark Hamilton
Mark Hamilton May 22, 2023 18:54
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
......roll on next year
Reply
0 0
Report
Mark Hamilton
Mark Hamilton Mar 28, 2023 9:05
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Time to jump on 1.95 is good enough for £300 sovs worth
Reply
0 0
Report
Ken Laing
Ken Laing Aug 25, 2022 10:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The market doesnt seem think it will be positive for some reason. My guess is there will be a delay again. The FDA has been rather busy with monkeypox and new covid vaccines lately
Reply
1 0
Report
Gary Smith
Gary Smith Aug 25, 2022 10:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Tim McCarthy has sent another company into administration and lost shareholders millions and millions. My fear is history repeating itself. His track record is simply shocking. This is a 12 page document issued by the FDA, this is comprehendive and serious. IMM on it’s way to less than 1p
Reply
0 0
Report
Ken Laing
Ken Laing Aug 25, 2022 10:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Gary Smith I dont think its quite over yet. I bought back in as I feel a buyout could being discussed at the moment
Reply
1 0
Report
Gary Smith
Gary Smith Aug 25, 2022 10:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ken Laing - You asked me a while beck where is tge 3.25p placing i touted. Gone even better then that and you can buy for circa 2.50p. IMM the charity that just keeps giving
Reply
0 0
Report
Ken Laing
Ken Laing Aug 25, 2022 10:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Gary Smith did you buy 3% stake?
Reply
0 0
Report
Gary Smith
Gary Smith Aug 23, 2022 15:58
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The conpany have restructured and turned things around. Much depends on FDA decidion on 29th August. If successful 15p if a duster 1p
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email